4
Changes in Ownership
Lexaria Bioscience Corp. Filed Acc 0001103780-16-000092
CEO bought 27,637 shares at an average $0.13 ($3,545)
From the SEC's structured data for this filing
Trades in this filing
BUNKA CHRISTOPHER · CEO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-08-24 | Purchase : show line 1 in the form | +3,000 | $0.13 | $375 | 7,183,342 | D |
| 2016-08-25 | Purchase : show line 2 in the form | +14,637 | $0.12 | $1,815 | 7,197,979 | D |
| 2016-08-25 | Purchase : show line 3 in the form | +5,000 | $0.13 | $655 | 7,202,979 | D |
| 2016-08-25 | Purchase : show line 4 in the form | +5,000 | $0.14 | $700 | 7,207,979 | D |
| Open-market purchases · 27,637 sh · avg $0.13 · $3,545 | ||||||
Loading xslF345X03/primary_doc.xml…